Clinical trial
Genetic Predictors of Raltegravir Penetration Into Cerebrospinal Fluid
NCT00729924
Study timeline
Study start (unknown)2008-08-01Date precision: month
Registry last updated2015-03-03
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
HIV Infectionsunresolved
Interventions
RaltegravirDRUG · verified · RxNorm: raltegravir
Sponsors & collaborators
Vanderbilt Universitylead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00729924 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.